Steroid alternatives known as SARMs, or selective androgen receptor modulators, were developed for people with age-related muscle loss, but the drugs, which were never approved by the FDA, are gaining popularity among elite athletes and soldiers. The FDA warns that SARMs might cause heart attack, stroke and liver damage, and a recent study found many drugs marketed as SARMs contain unapproved drugs and other hormones.
April 15 marked the end of a temporary waiver period that eased rules for Tricare Prime enrollees in the West seeking specialty care, but waivers ordered before that date are valid through June 15. Separately, a Government Accountability Office report said the Defense Health Agency has not fully developed an implementation plan for the new Tricare Select system.
Leaders from the Defense Health Agency, the VA and Fort Bragg met with elected officials and civilian health care providers to share best practices and discuss possible solutions to opioid misuse and addiction. Opioid prescribing has fallen within the VA health care system as providers prescribe more alternative pain treatments, but Dr. Padma Gulur of Duke Health said civilian health insurance policies and shortfalls in prescriber education hamper civilian efforts to reduce opioid prescriptions.
The US Preventive Services Task Force updated guidance issued in 2012 to recommend against use of vitamin D supplements by community-dwelling adults over age 65 to prevent falls. The report in the Journal of the American Medical Association said while there is insufficient evidence to support the use of vitamin D supplements, evidence clearly supports exercise to reduce the risk of falls.
Pain Management and Opioid Safety in the MHS The MHS Stepped Care Model seeks to provide patients with the most effective pain management guided by CPGs while avoiding chronic pain, reducing opioid use, and minimizing complications for the minority of patients requiring opioids. Click for details on this May 4th event at USO Ft. Belvoir.
Surgeons at Memorial Hermann Hospital in Houston have developed an experimental therapy for severe brain trauma using infusions of autologous bone marrow cells. The therapy is being studied in a Phase II clinical trial.
Researchers who followed 600 veterans found those who cut back on opioid medications or switched to a non-opioid drug or therapy still had pain at levels comparable to when they relied mostly on opioids, according to a study presented at the Society of Behavioral Medicine conference. Researchers said the data show pain may not increase for patients who stop taking opioid drugs.
MRCEE Series: Pain Management and Opioid Safety in the MHS. Join us Friday, May 4, at the USO -- Warrior & Family Center at Fort Belvoir for this informative seminar and networking event. The MHS Stepped Care Model seeks to provide patients with the most effective pain management guided by CPGs while avoiding chronic pain, reducing opioid use and minimizing complications for the minority of patients who do require opioids. CEs available. Space is limited, so register today!